Health apps could help older adults with anything from sleep to diabetes, but most don’t use them

Key findings about health app use by older adults


The percentage of adults age 50-80 who said they use a mobile app for a specific health-related purpose. Data from the National Poll on Healthy Aging from the University of Michigan CREDIT University of Michigan

Mobile apps make it possible to track everything from exercise and calories to blood pressure and blood sugar, and use the information to stay on target with health goals or managing a chronic condition.

But a new poll shows that most people over age 50 aren’t using such apps – and that those who might get the most help out of them are less likely to actually use them.    

Less than half (44%) of people age 50 to 80 have ever used a health-related app on their smartphone, wearable device or tablet, according to the new findings from the National Poll on Healthy Aging.

Those who say they are in poor health, and those with lower incomes or levels of education, were far less likely to have ever used such apps. Half of those who haven’t ever used a health app, or have stopped using them, said they are not interested in using them.

The percentage of older adults who currently use at least one app is even smaller, at 28%. One-third of this group uses an app to track exercise, while smaller percentages use apps to track sleep, weight, nutrition, blood pressure, to guide meditation, or to manage mental health and stress. One-quarter of current users have shared information from their apps with their health care providers.

And among older adults who have diabetes, just 28% use an app on their device to log their blood sugar levels and 14% use an app to log their medications. But nearly half of older people with diabetes say they would be interested in using an app in both of these ways.  

The poll is based at the University of Michigan Institute for Healthcare Policy and Innovation and supported by AARP and Michigan Medicine, U-M’s academic medical center.

“Now that most older adults have at least one mobile device, health-related apps can provide an opportunity to support their health-related behaviors, manage their conditions and improve health outcomes,” said Pearl Lee, M.D., M.S., a geriatrician at Michigan Medicine who worked on the poll report.

Lee and co-authors James Aikens, Ph.D., and Caroline Richardson, M.D., both of the U-M Department of Family Medicine, say the potential is especially important for older adults with diabetes.

The poll also included questions about continuous glucose monitors, which people with diabetes can wear on their skin to monitor their blood sugar over the long term. Such monitors can connect with mobile devices to feed readings into an app.

Only 11% of the poll respondents who have Type 2 diabetes said they currently use a CGM, though another 68% had heard of such devices and over half of them said they would potentially be interested in using one.

“AARP’s research has found a sharp increase in older adults purchasing and using technology during the pandemic, and many are interested in using technology to track health measures,” said Indira Venkat, Vice President, Consumer Insights at AARP. “With more people 50+ owning and using technology, we may start to see an increase in older adults using apps to monitor their health.”

Disparities in app use

Recent data show that 83% of people age 50 to 64, and 61% of people over age 65, own a smartphone, and just under half of people in each age group own a tablet device. That’s up from 34% of 50-64-year olds and 13% of those over 65 having a smartphone a decade ago, and even lower percentages having tablets at that time.

Despite this rise, the poll highlights disparities in the use of mobile health apps by income and education level, as well as age. It also shows that lack of awareness, or mistrust of the security of health apps may be holding many older adults back.

Poll director Preeti Malani, M.D., an infectious disease physician with training in geriatrics at Michigan Medicine, notes that older adults with incomes over $100,000 were nearly three times more likely than those with incomes under $30,000 to use health apps, at 43% vs. 15%. Those with college degrees were more than twice as likely to use health apps as those who had not completed high school.

“People who describe  their health as fair or poor – the people who might be most in need of the kind of tracking, support and information a good health app can give – were significantly less likely to use such apps than those who say they’re in excellent, very good or good health,” Malani notes. “Health providers should consider discussing the use of health apps with their patients, because one-third said they had never thought about using one.”

The poll report is based on findings from a nationally representative survey conducted by NORC at the University of Chicago for IHPI, and administered online and via phone in August 2021 among 2,110 older adults age 50–80. The sample was subsequently weighted to reflect the U.S. population. Read past National Poll on Healthy Aging reports and about the poll methodology

Amygdala changes in autistic individuals linked to anxiety

2-Minute Neuroscience: Amygdala - YouTube


A long-term study involving hundreds of brain scans finds changes in the amygdala linked to the development of anxiety in autistic children. The study by UC Davis MIND Institute researchers also provides evidence of distinct types of anxiety specific to autism. The work was published in Biological Psychiatry.

“I believe this is the first study that’s found any kind of biological association with these autism-distinct anxieties,” said Derek Sayre Andrews, postdoctoral scholar in the Department of Psychiatry and Behavioral Sciences and co-first author on the paper. “Anxiety is really salient right now with the pandemic, and it’s potentially debilitating to autistic individuals, so it’s important to understand what’s happening in the brain.”

The importance of the amygdala in autism and anxiety

The amygdala is a small, almond-shaped structure in the brain. It plays a key role in processing emotion, particularly fear, and studies have linked it to both autism and anxiety.

“We have known for some time that dysregulation of the amygdala is implicated in anxiety,” said David G. Amaral, UC Davis distinguished professor, Beneto Foundation Endowed Chair and co-senior author on the paper. “We’ve also shown previously that the growth trajectory of the amygdala is altered in many autistic individuals.”

Anxiety commonly occurs with autism. Previous research by Amaral and other MIND Institute researchers has found that the rate of anxiety is 69% in autistic children and 8% in non-autistic children.

But until now, no one had looked at the development of the amygdala over time in autistic individuals, in relation to different forms of anxiety.

Hundreds of brain scans

The research team used magnetic resonance imaging (MRI) to scan the brains of 71 autistic and 55 non-autistic children between the ages of 2 and 12. Children were scanned up to four times. All were participants in the Autism Phenome Project, a longitudinal study that started in 2006 at the MIND Institute.

Clinical psychologists with expertise in autism interviewed the parents about their child. The interviews were done when children were 9-12 years old. They included questions about traditional anxiety, as defined by the DSM-5, a manual used to diagnose mental health conditions. The psychologists used the Anxiety Disorders Interview Schedule (ADIS) as well as the Autism Spectrum Addendum (ASA), a tool developed to tease out autism-specific anxieties.

The results showed that nearly half of the autistic children had traditional anxiety or autism-distinct anxiety, or both. Autistic children with traditional anxiety had significantly larger amygdala volumes compared to the non-autistic children. The opposite was true for autistic children with autism-distinct anxieties: They had significantly smaller amygdala volumes.

“Previous studies were not teasing apart amygdala size in relation to these two different types of anxiety,” said Christine Wu Nordahl, a professor in the Department of Psychiatry and Behavioral Sciences and co-senior author on the paper. “We were reminded that different autistic subgroups may have different underlying brain changes. If we had lumped both traditional and distinct anxieties together, the amygdala changes would have canceled each other out and we would not have detected these different patterns of amygdala development.”

Nordahl and Amaral have tracked autism subgroups for 15 years in the Autism Phenome Project and have published numerous studies advancing the field of knowledge in this area.

“The real power of this particular study is that it tracks the trajectory of amygdala development from age 2 to age 12 to see if there are early predictors of these different types of anxiety – whether there are different patterns.” Nordahl said.

Autism-specific anxiety versus traditional anxiety

Prior research has suggested that anxiety in autistic individuals is complex. Some experience traditional anxiety, which can include fearful avoidance, in contexts experienced by non-autistic people. But others may experience anxiety in contexts that are distinctly specific to autism.

“It’s similar, but the context in which the anxiety arises is different,” Andrews explained. “It could be uncommon phobias like facial hair or toilet seats, or it could be fears relating to social confusion or excessive worries related to losing access to materials about something they’re really interested in. It’s anxiety arising within an autistic context.”

The research into autism-distinct anxiety is new, and the authors note that the results would need to be replicated, but the study makes a strong case for it.

“Given that clear brain alterations are associated with autism-distinct anxiety tends to validate the concept of the existence of this type of anxiety in autism,” Amaral said.

In fact, 15% of the participants in the study had only the distinct autism-specific anxiety.

“You can see why it’s important to acknowledge this, because these children would be missed through ordinary screening,” Andrews explained. He added that this type of anxiety may require a specialized type of treatment. “That’s why it’s important to understand the underlying biology of anxiety and autism and to help these kids out in any way that we can.”

In the future, the researchers plan to examine how the amygdala interacts with other regions of the brain.

“We don’t think the story ends with the amygdala,” Nordahl said. “We recognize that it doesn’t act all by itself and it’s critical to explore who the amygdala is talking to and what it’s doing through its network of connections with other brain regions.”

Coauthors on the paper included Leon Aksman of USC (co-first author); Conner M. Kerns of the University of British Columbia; Joshua K. Lee, Breanna M. Winder-Patel, Danielle Jenine Harvey, Einat Waizbard-Bartov, Brianna Heath, Marjorie Solomon and Sally Rogers of UC Davis, and Andre Altmann of University College, London.

Mid Back Stretches & Exercises for Pain Relief

Back Pain | Ask Doctor Jo


Mid back pain can make it difficult to perform everyday activities. Here are some of my favorite mid back stretches and exercises to help relieve the pain. Rhomboid stretch, thoracic side bend, and thoracic rotation are all simple stretches to get started. These should help loosen up tight mid back muscles and relieve pain in the mid back area. Seated Ts, seated rows, and bear hugs are all simple exercises to help strengthen the muscles. These should help loosen up tight mid back muscles and relieve pain in the mid back area as well.

Potential biomarkers identified for neuropsychiatric symptoms of lupus

Chandra Mohan, Hugh Roy and Lillie Cranz Cullen Endowed Professor of biomedical engineering at the University of Houston


Chandra Mohan, Hugh Roy and Lillie Cranz Cullen Endowed Professor of biomedical engineering at the University of Houston, screened more than 1,100 proteins in the fluid surrounding the brains of neuropsychiatric lupus patients and identified a few proteins that could potentially be used to diagnose neuropsychiatric lupus. CREDIT University of Houston

A globally renowned expert in autoimmune diseases and systemic lupus erythematosus (SLE) at the University of Houston has identified potential biomarkers for neuropsychiatric symptoms of lupus. Lupus is an autoimmune disease in which the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs. 

While most people with lupus experience a variety of symptoms that include fatigue, skin rashes, fever, and pain or swelling in the joints, about half of people with SLE suffer neuropsychiatric symptoms. Those include seizures, aseptic meningitis, acutely confused states, cerebrovascular disease psychosis and mood disorders.  

“The diagnosis of neuropsychiatric lupus is difficult because the neurological symptoms could very well be due to other causes. As no gold-standard diagnostic test exists for neuropsychiatric systemic lupus erythematosus (NPSLE), we executed a broad screen of NPSLE cerebrospinal fluid using an aptamer-based platform,” reports Chandra Mohan, Hugh Roy and Lillie Cranz Cullen Endowed Professor of biomedical engineering, in the journal Arthritis & Rheumatology. Aptamers are short sequences of nucleic acids that can be further selected based on their binding specificities. Commercially available libraries of aptamers allow comprehensive screening of >1000 human protein targets, representing some of the largest screening platforms currently available in targeted proteomics.  

Mohan’s team screened more than 1,100 proteins in the fluid surrounding the brains of neuropsychiatric lupus patients and identified a few proteins that could potentially be used to diagnose neuropsychiatric lupus. The proteins that showed up in most samples are CSF Lipocalin-2, M-CSF, IgM and complement C3.  

“These proteins emerged as promising cerebrospinal fluid biomarkers of NPSLE with diagnostic potential,” Mohan reported. “Elevated CSF C3 was associated with acute confusional state. Eleven molecules elevated in the fluid exhibited concordant elevation in the choroid plexus, suggesting shared origins.” 

Neuropsychiatric events occur most frequently early during the disease course in most cases, either as a presenting symptom or within the first five years of disease onset.  

Cerebrospinal fluid samples used in this study were provided by collaborators John Hanly from Dalhousie Lupus Clinic, Halifax, Nova Scotia, Canada and C.C. Mok from Tuen Mun hospital in Hong Kong, China. Laboratory studies were carried out by UH researcher Kamala Vanarsa in Mohan’s lab. 

“We believe proteomic investigations of blood and cerebrospinal fluid will eventually lead to the fabrication of a serum or cerebrospinal fluid-based diagnostic panel that permits accurate diagnosis of NPSLE, with significantly higher specificity for this disease, compared to other neuroinflammatory diseases or infections,” said Mohan.  

Professor George Jelinek Interview (Overcoming Multiple Sclerosis Handbook) – Nutrition and Lifestyle

Professor George Jelinek Interview (Overcoming Multiple Sclerosis Handbook)  - YouTube


George Jelinek is the first professor of emergency medicine in Australia and has over 150 scientific publications. He was diagnosed with MS in 1999 and promotes evidence based lifestyle advice in MS. He is the founder of the nonprofit overcoming multiple sclerosis